The Efficacy and Sofery of Topiram in Patients with Epilepsy
Shandan Ouyang
Abstract
Shandan Ouyang
Abstract
Objective:To observe the clinical efficacy and adverse reaction(AR)of topiramate(TPM)in treatment of epilepsy, and to explore the optimal mode of administration.Methods:One hundred and ninety-nine patients with epilepsy were divided into two groups according to different starting dose and the rate of increasing dosage,Group A (102 cases),the starting dose of TPM was 25 mg/d and the increasing dos-age per week was 25 mg until 200 mg/d was reached and then maintained for 12 wks;Group B(97 cases),the starting dose of TPM was 50mg/d and the increasing dosage per week was 50 mg until 200 mg// d was reached and then maintained for 12 weeks.Results:The total effective rate and controlrate in Group A were 77.7% and 42.1%;whereas those in Group B were 76.2 and 40.2,respectively.Significant difference was found between both groups(P>0.05).More ARs were observed in Group B as compared with Group A (P<0.05).Conclusion:A small starting dose fol- lowed by slowly increasing dosage is recommended to patients with lower seizure frequency.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the clinical efficacy and adverse reaction(AR)of topiramate(TPM)in treatment of epilepsy, and to explore the optimal mode of administration.Methods:One hundred and ninety-nine patients with epilepsy were divided into two groups according to different starting dose and the rate of increasing dosage,Group A (102 cases),the starting dose of TPM was 25 mg/d and the increasing dos-age per week was 25 mg until 200 mg/d was reached and then maintained for 12 wks;Group B(97 cases),the starting dose of TPM was 50mg/d and the increasing dosage per week was 50 mg until 200 mg// d was reached and then maintained for 12 weeks.Results:The total effective rate and controlrate in Group A were 77.7% and 42.1%;whereas those in Group B were 76.2 and 40.2,respectively.Significant difference was found between both groups(P>0.05).More ARs were observed in Group B as compared with Group A (P<0.05).Conclusion:A small starting dose fol- lowed by slowly increasing dosage is recommended to patients with lower seizure frequency.
Key concepts: Medicine, Topiramate, Epilepsy, Anesthesia, Adverse effect, Group B, Clinical efficacy, Significant difference